Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug875 | Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies Wiki | 1.00 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
There is objective need to evaluate the differences in dietary intake (DI), body composition (BC), lifestyle (LS) and cardiovascular diseases (CVD) risk factors between healthy and active vegetarinas (VEG) and non vegetarians (non VEG) and references (according to gender). The aim of this cross-sectional study for investigators is to document the potential differences in DI (non adjusted and adjusted), BC, LS and CVD risk factors between healthy and active VEG and non VEG, aged from 18 to 80 years, and to evaluated correlation between DI variables and CVD risk factors. The study during the COVID-19 pandemic period will be self-reported. As variables the investigators will include the dietary intake, BC (body height, body weight, body mass index (BMI), body fat percentage (BF %)), lifestyle status (physical activity, daily seating, hygiene of sleep, socio-economic status, and motive for practicing chosen diet). The investigators will also record their maximum (lifetime) body weight, lipids (total-cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides) and blood pressure (BP) status. The investigators hypothesis are: (H1): There are differences in DI and quality of the diet (compared with references). (H2): There are differences in BC between the VEG in non VEG (according to gender). (H3): The are no differences between in CVD risk factors between the VEG and non VEG (according to gender). (H4): The are no differences in the effect of two intervals of time restricted feeding (i.e., 8-12 hours vs. 12-16 hours) within dietary pattern (according to gender).
Description: Body weight measured with medically approved weighing scale
Measure: Body weight status Time: Cross-sectional (April-June 2020)Description: Height status measured with medically approved weighing scale with height rod
Measure: Height status Time: Cross-sectional (April-June 2020)Description: Measured weight and height will be combined to report BMI in kg/m2
Measure: Body mass index (BMI) status Time: Cross-sectional (April-June 2020)Description: Fat tissue mass measured with bioimpedance analysis
Measure: Fat tissue mass status Time: Cross-sectional (April-June 2020)Description: Dietary intake measured by food frequency questionnaire
Measure: Dietary intake status Time: Cross-sectional (May-June 2020)Description: Serum total cholesterol concentration
Measure: Serum cholesterol status Time: Cross-sectional (May 2019-June 2020)Description: Serum concentration of oxidized LDL-cholesterol
Measure: Oxidized Low Density Lipoprotein (LDL)-cholesterol status Time: Cross-sectional (May 2019-June 2020)Description: Serum HDL cholesterol concentration
Measure: Serum HDL cholesterol status Time: Cross-sectional (May 2019-June 2020)Description: Serum triglyceride concentrations
Measure: Serum triglyceride status Time: Cross-sectional (May 2019-June 2020)Description: Blood pressure status (systolic and diastolic)
Measure: Blood pressure status Time: Cross-sectional (May 2019-June 2020)Description: Socio-economic and demographic status measured using Nutritional behaviours of adults Slovenians from the point of of health prevention questionnaire (Slovenian National Institute of Health)
Measure: Socio-economic and demographic status Time: Cross-sectional (May-June 2020)Description: Physical activity status measured by The International Physical Activity Questionnaires
Measure: Physical activity status Time: Cross-sectional (May-June 2020)Description: Sleep status measured with The Pittsburgh Sleep Quality Index
Measure: Sleep status Time: Cross-sectional (May-June 2020)Description: Motives for dietary pattern status measured by investigators questionnaire
Measure: Motives for dietary pattern status Time: Cross-sectional (May-June 2020)Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports